{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:28:05Z","timestamp":1789421285198,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2984,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.jid.5700868","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T10:28:28Z","timestamp":1178792908000},"page":"2425-2437","source":"Crossref","is-referenced-by-count":42,"title":["Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma Cells"],"prefix":"10.1016","volume":"127","author":[{"given":"Frank K.","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar F.","family":"Fecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Walden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalid","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"D\u00fcrkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700868_bb0010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.critrevonc.2003.11.003","article-title":"Adult acute lymphoblastic leukaemia","volume":"50","author":"Bassan","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/sj.jid.5700868_bb0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1038\/sj.jid.5700868_bb0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ijc.21939","article-title":"The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L\/TRAIL","volume":"119","author":"Butler","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700868_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/32.2.6198355","article-title":"Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)","volume":"32","author":"Cordell","year":"1984","journal-title":"J Histochem Cytochem"},{"key":"10.1038\/sj.jid.5700868_bb0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700868_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2133.2000.03889.x","article-title":"Decreased expression of Fas (APO-1\/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas","volume":"143","author":"Dereure","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1038\/sj.jid.5700868_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcp.20099","article-title":"Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)\/Apo2L","volume":"201","author":"Di Pietro","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1038\/sj.jid.5700868_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells","volume":"92","author":"Dobbeling","year":"1998","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0560.1995.tb00733.x","article-title":"Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates","volume":"22","author":"Dummer","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1038\/sj.jid.5700868_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14728222.10.1.27","article-title":"The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer","volume":"10","author":"Dutton","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/sj.jid.5700868_bb0070","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1038\/sj.onc.1207228","article-title":"CD95\/Fas signaling in human melanoma cells: conditional expression of CD95L\/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants","volume":"22","author":"Eberle","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700868_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.onc.1209015","article-title":"Unique and overlapping substrate specificities of caspase-8 and caspase-10","volume":"25","author":"Fischer","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700868_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnci\/58.2.209","article-title":"Absence of HeLa cell contamination in 169 cell lines derived from human tumors","volume":"58","author":"Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700868_bb0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","article-title":"Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia","volume":"18","author":"Foley","year":"1965","journal-title":"Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2005.05656.x","article-title":"Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death","volume":"130","author":"Georgakis","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1038\/sj.jid.5700868_bb0095","doi-asserted-by":"crossref","first-page":"14008","DOI":"10.1074\/jbc.273.22.14008","article-title":"Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates","volume":"273","author":"Giri","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.jid.5700868_bb0100","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1016\/j.febslet.2005.10.007","article-title":"Apo2L\/TRAIL is an indirect mediator of apoptosis induced by interferon-alpha in human myeloma cells","volume":"579","author":"Gomez-Benito","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1038\/sj.jid.5700868_bb0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","article-title":"Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor","volume":"154","author":"Gootenberg","year":"1981","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5700868_bb0110","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700868_bb0115","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1053\/j.seminoncol.2005.12.018","article-title":"Combination treatment modalities in cutaneous T-cell lymphoma (CTCL)","volume":"33","author":"Guitart","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1038\/sj.jid.5700868_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1196\/annals.1313.012","article-title":"Central memory and effector memory subsets of human CD4(+) and CD8(+)","volume":"1050","author":"Gupta","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/sj.jid.5700868_bb0125","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.cdd.4401157","article-title":"Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation","volume":"10","author":"Hopkins-Donaldson","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1038\/sj.jid.5700868_bb0130","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.cdd.4401535","article-title":"Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies","volume":"11","author":"Inoue","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1038\/sj.jid.5700868_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature03337","article-title":"CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death","volume":"434","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700868_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1038\/sj.jid.5700868_bb0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00431220","article-title":"A continuous T-cell line from a patient with Sezary syndrome","volume":"279","author":"Kaltoft","year":"1987","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/sj.jid.5700868_bb0150","doi-asserted-by":"crossref","first-page":"46639","DOI":"10.1074\/jbc.M105102200","article-title":"Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8","volume":"276","author":"Kischkel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.jid.5700868_bb0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700868_bb0160","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.0022-202X.2005.23900.x","article-title":"Efficient TRAIL-RI\/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related aptosis-inducing ligand (TRAIL)","volume":"125","author":"Kurbanov","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700868_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.21824","article-title":"SAHA-sensitized prostate cancer cells to TNFalpha-related apoptosis-inducing ligand (TRAIL): mechanisms leading to synergistic apoptosis","volume":"119","author":"Lakshmikanthan","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1242\/jcs.01610","article-title":"Death receptor signaling","volume":"118","author":"Lavrik","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1038\/sj.jid.5700868_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1044-5323(03)00030-7","article-title":"Function and regulation of the CD95 (APO-1\/Fas) ligand in the immune system","volume":"15","author":"Li-Weber","year":"2003","journal-title":"Semin Immunol"},{"key":"10.1038\/sj.jid.5700868_bb0180","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1038\/sj.onc.1205853","article-title":"Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia","volume":"21","author":"MacFarlane","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700868_bb0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.20031080","article-title":"c-FLIP mediates resistance of Hodgkin\/Reed\u2013Sternberg cells to death receptor-induced apoptosis","volume":"199","author":"Mathas","year":"2004","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5700868_bb0190","first-page":"891","article-title":"Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes","volume":"49","author":"Minowada","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700868_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"Muller","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1038\/sj.jid.5700868_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000080999","article-title":"Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions","volume":"67","author":"Nagasawa","year":"2004","journal-title":"Oncology"},{"key":"10.1038\/sj.jid.5700868_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2004.11.054","article-title":"Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"225","author":"Oehadian","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1038\/sj.jid.5700868_bb0210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700868_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1396-0296.2003.01643.x","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"16","author":"Olsen","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1038\/sj.jid.5700868_bb0220","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood-2005-06-2601","article-title":"c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma","volume":"107","author":"Oyarzo","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0225","first-page":"25","article-title":"Does CD95 have tumor promoting activities?","volume":"1755","author":"Peter","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/sj.jid.5700868_bb0230","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.bjc.6602487","article-title":"HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo","volume":"92","author":"Pukac","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0235","first-page":"11","article-title":"Apoptosis mechanisms: implications for cancer drug discovery","volume":"18","author":"Reed","year":"2004","journal-title":"Oncology (Williston Park)"},{"key":"10.1038\/sj.jid.5700868_bb0240","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2004-07-2761","article-title":"Apoptosis-based therapies for hematologic malignancies","volume":"106","author":"Reed","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","article-title":"Bortezomib: proteasome inhibition as an effective anticancer therapy","volume":"57","author":"Richardson","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1038\/sj.jid.5700868_bb0250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Riedl","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/sj.jid.5700868_bb0255","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.97.5.695","article-title":"Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix","volume":"97","author":"Scherer","year":"1953","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jid.5700868_bb0260","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.2910190505","article-title":"Characterization of EBV-genome negative \u201cnull\u201d and \u201cT\u201d cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma","volume":"19","author":"Schneider","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pros.20126","article-title":"Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo","volume":"62","author":"Shankar","year":"2005","journal-title":"Prostate"},{"key":"10.1038\/sj.jid.5700868_bb0270","first-page":"1125","article-title":"Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways","volume":"16","author":"Shankar","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1038\/sj.jid.5700868_bb0275","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood.V99.11.4094","article-title":"Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas","volume":"99","author":"Shin","year":"2002","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0280","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(73)90469-8","article-title":"Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin","volume":"1","author":"Smith","year":"1973","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5700868_bb0285","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2141.1997.4393250.x","article-title":"Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies","volume":"99","author":"Snell","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1038\/sj.jid.5700868_bb0290","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910490218","article-title":"Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor","volume":"49","author":"Starkebaum","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700868_bb0300","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1104765","article-title":"Requirement for caspase-8 in NF-kappaB activation by antigen receptor","volume":"307","author":"Su","year":"2005","journal-title":"Science"},{"key":"10.1038\/sj.jid.5700868_bb0305","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5700868_bb0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/sj.jid.5700868_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"10.1038\/sj.jid.5700868_bb0320","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700868_bb0325","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.jid.5700868_bb0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexcr.2005.06.021","article-title":"Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells","volume":"310","author":"Yanase","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1038\/sj.jid.5700868_bb0335","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","article-title":"Selective induction of apoptosis by histone deacetylase inhibitor suberoylanilide hydroxamic acid in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"125","author":"Zhang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700868_bb0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.1341","article-title":"Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells","volume":"200","author":"Zhang","year":"2003","journal-title":"J Pathol"},{"key":"10.1038\/sj.jid.5700868_bb0345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cdd.4401138","article-title":"Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation","volume":"10","author":"Zhang","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1038\/sj.jid.5700868_bb0350","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.2000.03656.x","article-title":"Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL","volume":"143","author":"Zoi-Toli","year":"2000","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15331511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15331511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T21:13:42Z","timestamp":1587503622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15331511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0022202X15331511"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700868","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}